AIM: To explore the effect of Obtusifolin on retinal pigment epithelial cell growth under hypoxia. • METHODS: In vitro chemical hypoxia model of ARPE-19 cells was established using cobalt chloride (CoCl 2 ).
INTRODUCTION
A s a degenerative cause, choroidal neovascularization (CNV) is the pathological basis of various eye diseases such as age-related macular degeneration (AMD), myopic macular degeneration (PM) and central exudative chorioretinopathy (CEC) [1] [2] [3] [4] [5] . The mechanism of occurrence and development of CNV is complex, the principle is not yet clear, and treatment is difficult. Current treatments for CNV include surgery to remove or block CNV, intravitreal injections of anti-angiogenic drugs such as anti-vascular endothelial growth factor (VEGF), and using of glucocorticoids and inflammatory reactions [6] [7] [8] . However, the efficacies of the above methods are not satisfactory, because of poor long-term efficacy, high recurrence rate, high price, and many adverse reactions [6] [7] [8] . Although modern medicine has developed rapidly in CNV studies, the clinical efficacy of current CNV is not effective. Therefore, it is of great significance to explore new treatments. Semen Cassiae is dry, mature seed of the leguminous plant Cassia obtusifoiia L. or Cassia tora L. It is an ancient Chinese medicine that can be used as a food and medicine [9] . The main active ingredient of cassia is Obtusifolin, which has antioxidant and nominal effects [10] . Study has reported that the activity of ciliary lactate dehydrogenase (LDH) in obtusifolinfed dogs and rabbits was significantly elevated [8] . Therefore, we speculate that Obtusifolin has effects on the treatment of CNV. The generation of blood vessels refers to the process of forming a new capillary network by sprouting or intussusception after the body or tissue receiving the stimulus [11] . Current research suggests that hypoxia is one of the most important causes of the occurrence and development of CNV and studies have confirmed that VEGF plays a key role in the formation of CNV [12] [13] . The hypoxia inducible factor-1(HIF-1)/VEGF/ eNOS pathway is mainly induced by hypoxic environment, activates eNOS release of NO and other factors through signal transduction, regulates cell proliferation, apoptosis, and migration [14] [15] . It is considered that VEGF-related pathways and proteins are overexpressed in ocular diseases where CNV is the pathological basis [16] [17] . This study explored the effects of Obtusifolin on cell viability and VEGF in human retinal epithelial cells under hypoxic conditions, and explored its effects on CNV.
MATERIALS AND METHODS

Cells Culture and Observation
The human retinal epithelial cells line (ARPE-19) was purchased from ATCC (USA). The cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum and 100 U/mL of penicillin-streptomycin mixture in an incubator at 37℃ in 5% CO 2 . According to different groups, the corresponding concentration (100, 200, 400 μg/mL) of Obtusifolin was added to the culture medium and incubated at 37℃ in 5% CO 2 for 24h. Obtusifolin was dissolved in DMSO and the amount of DMSO did not exceed 0.1% of the total volume of the medium. An in vitro chemical hypoxia model was established by adding cobalt chloride (CoCl 2 ; Sigma, USA) to the culture medium. Cell culturerelated reagents were purchased from Gibco (USA). All cells in this experiment were within 5 passages. ARPE-19 cells morphology was observed through a light microscope (Nikon, Japan). Cell Viability Analysis Cell counting kit-8 (CCK-8) assay was used to detect cell viability at 12, 24, and 48h after added 0, 50, 100, 150, 200 μmol/L CoCl 2 . The kit was purchased from Tongren (Japan). Diluted CCK-8 reagent were added and cultured at 37℃ in 5% CO 2 atmosphere for 4h. The absorbance of each well at 450 nm was measured using a microplate reader (ELX 800, Bio-Teck, USA), and cell viability was calculated according to the standard curve.
Real-time Quantitative Polymerase Chain Reaction
Analysis Real-time quantitative polymerase chain reaction analysis (RT-qPCR) was used to detect the mRNA expression levels of HIF-1α, Cyclin D1, proliferating cell nuclear antigen (PCNA), p53, p21, VEGF, VEGFR2 and eNOS. The cells were triturated and lysed using Trizol (TaKaRa, Japan) at 0℃ for 5min. The RNAs were extracted by CCl 3 (Aladdin, China) and dissolved in DEPC water (Sigma aliquots). RNA concentration was measured by using a UV spectrophotometer (NanoDrop One Microvolume UV-Vis spectrophotometer, Thermofisher, USA). Reverse transcription assays were performed on RNA samples using a reverse transcription kit (TaKaRa, Japan) to synthesize cDNA. Reverse transcription reaction conditions was 37℃ for 15min and reverse transcriptase inactivation condition was 85℃ for 15s. RT-qPCR experiments were performed with the SYBR Prellix Ex TaqTM Real-Time PCR Kit (TaKaRa, Japan). PCR was performed by activating the DNA polymerase at 95℃ for 5min, followed by 40 cycles of two-step PCR (95℃ for 10s and 60℃ for 30s) and a final extension at 75℃ for 10min and held at 4℃. DnaSe and RNase-free water were used as the templates of negative control experiences. All primers were obtained from Genewiz (Suzhou, Jiangsu China) and listed in Table 1 . GAPDH was considered as an internal control. The formula 2 -ΔΔCT was implemented to analyze the gene expression. Western Blot Western blot was applied to detect protein expression. Cells were lysed with liquid nitrogen and blocked with RIPA (Abmole, USA), followed by 1% cleavage in PMSF and phosphatase inhibitors (Abmole, USA) and lysis for 30min at 4℃. The supernatant was collected by centrifugation at 12 000 rpm at 4℃ for 15min. A standard curve was drawn using the BCA method to determine the protein concentration. A 10% SDS-PAGE gel was prepared without RNase dH 2 O and used to electrophoresis. The PVDF membrane (Bio-Rad, USA) was transferred using a Trans-Blot Transfer Slot (Bio-Rad, USA) and blocked with 5% fat-free milk for 2h at room temperature. The primary antibody (anti-HIF-1α, Abcam, ab51608, dilution: 1:800; anti-Cyclin D1, Abcam, ab134175, dilution: 1:800; anti-PCNA, ab29, Abcam, dilution: 1:700; anti-p53, Abcam, ab26, dilution: 1:600; anti-p21, Abcam, ab109520, dilution: 1:600; anti-VEGF, Merck Millipore, ABS82, dilution: 1:800; anti-VEGFR2, Abcam, ab2349, dilution: 1:600; anti-eNOS, Abcam, ab76198, dilution: 1:900) was added according to the kit instructions, shaking at room temperature for 2h, then incubated at 4℃ for 12h. The secondary antibody (goat anti-mouse IgG, Abcam, ab6785, 1:8000; rabbit anti-mouse IgG, Abcam, ab99697, dilution: 1:9000; mouse anti-rabbit IgG, Invitrogen, BA1034, 1:7000; donkey anti-rabbit IgG, R&D, NL004, 1:5000; rabbit antihuman IgG, Abcam, ab6759, dilution:1:10000) was added and incubated at room temperature for 1.5h. Chemiluminescence detection was carried out use ECL reagent (Huiying, Shanghai, China). Evaluation of Cell Cycle Cell cycle was tested by flow cytometry. The cells were collected and washed with PBS at 0℃, and then fixed with 75% ethanol at -20℃ for 12h. After fixation, the cells were treated with 10 μL of RNase A (10 mg/mL, TaKaRa, Japan) for 30min at 37℃. And then detected by flow cytometer (Becton Dickerson, SanJose, CA, USA). The flow cytometry results were processed by FlowJo V10 software (Becton, Dickinson & Company, USA). Enzyme Linked Immunosorbent Assay The VEGF concentration of culture fluid was tested using enzyme linked immunosorbent assay (ELISA). The kits were purchased from Nanjing Kaiji Biotechnology Co., Ltd. (China). The primary antibody was added at 4℃ overnight, after washing blocking solution was added at 4℃ for 2h. And then the secondary antibody was added and incubated for 1h at room temperature. Horseradish peroxidase (HRP) was dropwised for 0.5h at room temperature, and tetramethylbenzidine (TMB) was added for 10min. The absorbance value was measured at 450 nm by a microplate reader (ELX 800, Bio-Teck, USA) and the concentration was calculated according to the standard curve. Statistical Analysis All the experimental data were presented as mean±standard deviation (SD). Statistical analysis used SPSS 20 (SPSS, Inc., Chicago, IL, USA). The one-way analysis of variance (ANOVA) following Turkey's multiple comparison was carried out to evaluate the differences between the experimental groups. The statistical significant was expressed as P<0.05.
RESULTS
Changes of Cell Viability in Hypoxia
The viable ARPE-19 macrophages were normal at 100-fold and 200-fold observations ( Figure 1A) . The cell viability gradually increased with the increase of CoCl 2 concentration and the passage of time. The maximal cell viability was observed in 200 μmol/L CoCl 2 at 48h ( Figure 1B) . To test the successful establishment of a chemical hypoxia model, HIF-1α mRNA and protein were detected after added CoCl 2 24h. The expression of HIF-1α mRNA and protein gradually increased and the maximal HIF-1α mRNA was in 150 μmol/L CoCl 2 (Figure 1C, 1D ). This proved that the chemical hypoxia model was successfully established. The hypoxic environment has the effect of increasing the viability of human retinal epithelial cell lines. The subsequent experimental hypoxia model were established under a CoCl 2 concentration of 150 μmol/L.
Effects of Obtusifolin on ARPE-19 Cells under Hypoxia
To study the effects of Obtusifolin on ARPE-19 cells under a hypoxic environment, cells were pretreated with 100, 200, and 400 μg/mL Obtusifolin before adding CoCl 2 . The cell viability gradually and cell count were all decreased with the increase of the concentration of Obtusifolin, and the cell viability in 400 μg/mL concentrations was similar to that of the control group. This suggests that Obtusifolin could reduce ARPE-19 cells viability under hypoxic condition (Figure 2A, 2B) . To explore the factors that influenced the viability of ARPE-19 cells by Obtusifolin, the cell cycle was examined by using flow cytometry. Chemical hypoxia caused the ARPE-19 cells to enter the S phase to accelerate the division. Obtusifolin could restore the cell cycle under a hypoxic environment similar to the control group. This indicates that the viability and proliferative capacity of the ARPE-19 cells were inhibited in the presence of Obtusifolin ( Figure 2C-2E ).
Effects of Obtusifolin on Cell Cycle Associated Protein
To investigate the effects of 100, 200, 400 μg/mL Obtusifolin on the cell cycle under hypoxic environments, the expression levels of cell cycle-associated proteins and mRNAs were determined by Western blot and RT-qPCR. When ARPE-19 cells were under hypoxic conditions, the levels of Cyclin D1 and PCNA protein and mRNA were significantly increased while the levels of p53 and p21 were decreased (Figure 3) . The presence of Obtusifolin inhibited the expression of Cyclin D1 and PCNA in hypoxic conditions and up-regulated p53 and p21 levels. With the concentration of Obtusifolin increased, the effects increased (Figure 3 ). This suggested that hypoxia could promote cell proliferation and division by regulating cell cycle-associated proteins, while Obtusifolin could reduce cell proliferation by affecting cell cycle-associated proteins and promote cells retention in the G1 phase. , Vol. 12, No. 10, Oct.18, 2019 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com
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Effects of Obtusifolin on HIF-1, VEGF, and eNOS
To study the effects of Obtusifolin on the HIF-1, VEGF, and eNOS in the hypoxic cell model, the expression levels of the relevant mRNA and protein in the pathway were detected by RT-qPCR and Western blot respectively. When ARPE-19 cells were exposed to hypoxia, the levels of HIF-1α, VEGF, VEGFR2 and eNOS proteins and mRNA were significantly increased (Figure 4) . Obtusifolin could dose-dependently down-regulate the expression of the pathway to make it close to the control group (Figure 4) . The level of VEGF secreted by ARPE-19 cells was significantly elevated under the induction of hypoxia. Obtusifolin dosedependently down-regulated VEGF secretion ( Figure 4F ). 
Effects of Obtusifolin on ARPE-19 Cells The effects of different concentrations of Obtusifolin on cells was observed
under a microscope ( Figure 5 ). The possible mechanism of Obtusifolin was shown in Figure 6 .
DISCUSSION
The main pathological basis of angiogenesis caused by hypoxia or inflammatory cytokines is overexpression of VEGF [18] . Angiogenesis is a complex process that involves the proliferation, migration and tube formation of vascular endothelial cells [19] [20] . CNV blood vessels mainly come from the retinal pigment epithelial cell [18] , so this study uses human retinal pigment epithelial cells line ARPE-19 cells as the research object. CoCl 2 has a low affinity with O 2 and does not have the effect of regulating O 2 concentration. However, Co 2+ can replace the chelation of Fe 2+ and hemoglobin, which destroys the ability of cells to sense hypoxia and thus mimic the hypoxic microenvironment [21] . The study also finds that CoCl 2 can protect cells through anti-apoptosis pathways, and the method is simple, stable and easy to control [22] . Therefore, CoCl 2 was used to simulate an in vitro chemical hypoxia microenvironment in this study. The results showed that the HIF-1α and cell viability were increased in a dosedependent manner in the ARPE-19 cells treated with CoCl 2 , demonstrating the successful establishment of an in vitro chemical hypoxia model.
Obtusifolin, including Emodin, Chrysophanol, Rhein, and
Aloe-emodin, has a variety of biological activities, of which the eyesight is one of its most importance [10] . The results of this study showed that Obtusifolin had the effect of reducing the cell viability of ARPE-19 cells under hypoxic conditions. Further studies have also found that Obtusifolin could promote the retention in the G1 phase and inhibit the proliferation of ARPE-19 cells. Hou et al [23] found that Obtusifolin has the effect of promoting apoptosis of retinal capillary cells in diabetic retinopathy rats. And other studies suggest that for hyperlipidemic rats, Obtusifolin shows anti-oxidation and NO regulation [24] . This showed that Obtusifolin inhibits the proliferation and differentiation of ARPE-19 cells, suggesting that it has a certain anti-angiogenic ability.
To further explore the mechanism of the effect of Obtusifolin 
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Int J Ophthalmol, Vol. 12, No. 10, Oct.18, 2019 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com important proteins that regulate cell cycle, it can bind and activate the unique cyclin-dependent kinase CDK4 during G1, promoting cell cycle progression from G1 to S, thereby promoting cell proliferation [25] . PCNA is involved in cellular DNA synthesis. PCNA was not expressed in G0-G1 phase cells, but it was significantly increased in the late G1 phase, and PCNA was a sensitive indicator of cell cycle response [26] . As a tumor suppressor gene, p53 has the effect of inhibiting cell proliferation by tissue cycle [27] . The p21 gene is a member of the Clp family and it is a cyclin-dependent kinase inhibitor downstream of the p53 gene [28] . P21 can together with p53 constitute the cell cycle G1 checkpoint [29] . The results of this study suggest that Obtusifolin could inhibit cell proliferation by up-regulating tumor suppressor genes and down-regulating cyclin proteins. The proliferation of cells is affected by a variety of cellular pathways. For the proliferation of retinal pigment epithelial cells and the formation of blood vessels, the largest influencing factor is the hypoxic microenvironment, and overexpression of VEGF is the main cause of vascular proliferation [30] [31] . HIF-1 is a key upstream transcription factor in angiogenesis signaling pathway, HIF-1 can be divided into HIF-1α and HIF-1β [32] . When the body is under hypoxia, it will induce high expression of HIF-1α, and it will up-regulate the expression of VEGF after binding with VEGF gene through hypoxia response element (HER) [33] . As a key protein in the pathway, VEGF mainly promotes the release of eNOS and NO through the activation of PI3K/Akt, MAPK and JAK/STAT pathway [34] [35] [36] . NO is an essential angiogenesis profile factor [37] [38] . On the other hand, PI3K/Akt and other pathways also have the effect of promoting cell proliferation and anti-apoptosis [39] [40] . The results of this study indicated that the hypoxic microenvironment could promote the expression and secretion of VEGF by increasing the expression of HIF-1α, and promote the expression of VEGFR2 and eNOS. Obtusifolin could down-regulate the HIF-1α, decrease the expression and secretion of VEGF. Previous studies have shown that improving the hypoxic state can play an anti-angiogenic role by inhibiting VEGF [41] [42] . Studies have also found that inhibiting the expression and secretion of VEGF can exert an anti-angiogenic effect by inhibiting the expression of NO [43] . Tang and Zhong's study [44] shows that Obtusifolin can regulate oxidative stress levels associated with obesity and diabetes. Obtusifolin regulates the levels of SOD and MDA to down-regulate oxidative stress levels. In addition, the study also finds that Obtusifolin regulates the level of NO [44] . Study has also shown that Obtusifolin could reduce the level of inflammatory factors by inhibiting nuclear factor-kappa B, which might also be related to angiogenesis [45] . This study first discovered that Obtusifolin could inhibit angiogenesis by inhibiting signal transduction by downregulating HIF-1α and reducing VEGF expression. In addition, Obtusifolin may also inhibit VEGF expression and may also inhibit cell proliferation by inhibiting VEGF related pathways and further studies are needed. Hypoxia could promote angiogenesis possibly by inducing the expression of VEGF, while Obtusifolin could inhibit the expression and secretion of VEGF by down-regulating HIF-1α, thereby reducing the inhibition of angiogenesis by eNOS.
